Authors: B. Mladosievičová; A. Foltinová 1; H. Petrášová; M. Čulen 2; P. Paulovič 2; I. Hulín Authors‘ workplace: Oddelenie klinickej patofyziológie LFUK, Bratislava, prednosta prof. MUDr. I. Hulín, DrSc. Onkologické oddelenie DFNsP, Bratislava, 1primárka doc. MUDr. E. Kaiserová, CSc. Detské kardiocentrum DFNsP, Bratislava, 2primár MUDr. M. Hrebík Published in: Čes-slov Pediat 2001; (4): 209-213. Category:
Chemotherapy with anthracycklines, even in recommended dosage, is associated with an increased incidence of subclinical and clinical cardiotoxic abnormalities. In this study frequency-dopamin parameters of the ECG signal using high resolution electrocardiography were repeatedly analyzed in 50 paediatric oncological patients after anticancer therapy and in 120 healthy volunteers. Frequency components were significantly higher in cancer survivors than in control subjects. In 12% oncologic patients an abnormal frequency spectrum persisted during the whole follow up (median 6 years after therapy). Persistent frequency abnormalities were not found in healthy subjects. Differences in frequency in the QRS complex between patients and controls might signalize an initial stage of anthracycline-induced myocardial damage.
Key words: anthracycline cardiotoxicity, high resolution ECG, frequency-domain analysis
Don‘t have an account? Create new account
Enter the email address that you registered with. We will send you instructions on how to set a new password.
